Active

FEBELFARMA

Switched

BE0479127936

Rechtspersoon Private limited company 1 establishment

Eigenlostraat 1, 9100 Sint-Niklaas Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Active for

23 year, 8 months

Financials

Financial year 2025

Revenue

€ 59,365

▲ 48% vs 2024

Profit

Healthy

€ 45,753

▼ 92% vs 2024

Debts

Low

€ 29,699

▲ 105% vs 2024

FEBELFARMA from Sint-Niklaas, company number BE0479127936, closed financial year 2025 with a result of € 45,753 after tax. For that financial year FEBELFARMA recorded revenue of € 59,365 and equity of € 2 million. Compared with financial year 2024, the result moved from € 608,557 to € 45,753. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What happened at FEBELFARMA?

What happened at FEBELFARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 45,753 (▼ 92% vs 2024). filed late Source: NBB ↗
  • New establishment in Sint-Niklaas. KBO
  • Start of the company according to the CBE. KBO

In short

From € 137,077 loss in 2021 to € 45,753 profit in 2025.

Paid € 35,867 in corporate taxes since 2021.

Best year ever: 2024, with € 608,557 profit.

Pays suppliers within 100 days on average.

A new publication or filing at FEBELFARMA? We notify you, reason included.

Follow FEBELFARMA

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Eric Van Nueten
FEBELFARMA

Behind FEBELFARMA are Alexo BV, Aristo BV and Eric Van Nueten. It owns 25% of Pharmacie Coloniale, 0.1% of Axone Pharma and 0% of Livlina itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Alexo BV

Managing director · represented by Olivier Delaere

Also active at: SDC, HC Pharma, SODIAP +39 more

Aristo BV

Chairman of the board · represented by Frank Coene

Also active at: LIVLINA, FEBELCO, FEBELCOFONDS +2 more

Eric Van Nueten

Director

Also active at: APOTHEEK MOLENVELD, FEBELCO, FEBELCOFONDS +2 more

Establishments

Establishment units

Physical locations of this company

Registered office

Eigenlostraat 1

9100 Sint-Niklaas

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.

Details

Company number
0479.127.936
VAT number
BE 0479.127.936
Registered office
Eigenlostraat 1, 9100 Sint-Niklaas
Names & denominations
FEBELFARMA
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
23 December 2002
Peppol
Active · Active since 23 Dec 2025
Activities · NACE

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsvoering en beheer

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Overige vormen van onderwijs

Frequently asked questions

What is the enterprise number of FEBELFARMA?
The enterprise number of FEBELFARMA is BE0479127936.
What is the address of FEBELFARMA?
The registered office of FEBELFARMA is located at Eigenlostraat 1, 9100 Sint-Niklaas.
When was FEBELFARMA founded?
FEBELFARMA was founded on 23 December 2002.
What is the main activity of FEBELFARMA?
The main activity of FEBELFARMA is "Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies" (NACE code 70200).
Does FEBELFARMA have a website?
No website is currently known for FEBELFARMA.
How much profit did FEBELFARMA make in 2025?
FEBELFARMA posted a profit after taxes of € 45,753 in financial year 2025.
What is the revenue of FEBELFARMA?
In its most recent annual accounts (2025), FEBELFARMA reported revenue of € 59,365.
Where can I find the annual accounts of FEBELFARMA?
FEBELFARMA files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of FEBELFARMA?
According to the 2025 annual accounts, the directors of FEBELFARMA are: Alexo BV, Aristo BV, Eric Van Nueten.
Who owns FEBELFARMA?
Behind FEBELFARMA are Alexo BV, Aristo BV and Eric Van Nueten. It owns 25% of Pharmacie Coloniale, 0.1% of Axone Pharma and 0% of Livlina itself.